Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

reports "Minneapolis Mayor Jacob Frey requested support from the guard 'out of an abundance of caution and for the sake of preparedness,' spokesman Mychal Vlatkovich said." The Tribune says "Cahill's rulings Thursday are his most significant pretrial decisions since he was assigned the case this past summer," res

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

reports "Minneapolis Mayor Jacob Frey requested support from the guard `out of an abundance of caution and for the sake of preparedness,' spokesman Mychal Vlatkovich said." The Tribune says "Cahill's rulings Thursday are his most significant pretrial decisions since he was assigned the case this past summer," re

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

reports "Minneapolis Mayor Jacob Frey requested support from the guard 'out of an abundance of caution and for the sake of preparedness,' spokesman Mychal Vlatkovich said." The Tribune says "Cahill's rulings Thursday are his most significant pretrial decisions since he was assigned the case this past summer," re